Project Grant HT9425261E017
Award Date 7/1/26
Completion Date 6/30/30
Dollars Obligated $4.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60606, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Duke University $3.82M under the Military Medical Research and Development program (CFDA 12.420) for a four-year project beginning July 1, 2026. The award supports long-term follow-up research of the Comparison of an Operation to Monitoring, with Option of Endocrine Therapy (COMET) study. The primary deliverables include clinical trial execution, longitudinal patient monitoring, and translational research activities designed...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $5.34 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2025, for a four-year performance period concluding June 14, 2029. The award supports development and implementation of a digital health intervention designed to enable self-management and telemonitoring capabilities for patients undergoing Chimeric Antigen Receptor...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $672,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research investigating a novel synthetic lethal vulnerability in anaplastic thyroid cancer through inhibition of one-carbon metabolism. This two-year research initiative will be conducted at the institution's...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.344 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2029. The award supports research on targeting noncanonical Wnt signaling to prevent Ewing sarcoma metastases utilizing a novel zebrafish model. This research addresses a critical cancer biology challenge relevant to military medical...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $177,992 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2027. The award supports the generation of novel tools and development of targeted approaches for AL (light-chain) amyloidosis, a serious protein misfolding disorder. Research activities will be conducted at the Institute's...
- Federal Project Grant Award Summary Dana-Farber Cancer Institute, Inc. (DFCI) received a $2.0 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2026, with a performance period extending through September 29, 2030. The award supports the Prostate Cancer Clinical Trials Consortium, which will be conducted at DFCI's Boston, Massachusetts location. Under this funding mechanism, DFCI will deliver...
- Federal Grant Award Summary Beckman Research Institute of the City of Hope received a $2.136 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The award supports developmental therapeutics research and the investigation of potential treatment strategies targeting RALBP1 (Retinoid-binding Protein 1) for castration-resistant prostate carcinoma. This...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. (DFCI) received a $1.424 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded August 1, 2025, with a performance period through July 31, 2029. The award supports research to expand the targetable tumor antigen repertoire of renal cell carcinoma, positioning the work within DHA's broader portfolio of hypothesis-driven biomedical research...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...